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• Pulmonary hypertension is a common and serious con- 
dition, either as a primary event or secondary to other injury. 
In its clinical form there is always a restrictive lesion caused 
by vascular cell proliferation. This narrows the lumen of ves- 
sels throughout the lung but especially ones forming the mi- 
crocirculation, the smallest vessels that lie adjacently to the 
capillaries. In addition, contractile cells develop in segments 
v/here normally these cells are absent (neomuscularization). 
As these cells form elastic laminae and organize into intimal 
and medial layers, microvascular segments that resemble cap- 
illaries in wall structure are converted into thick-walled ves- 
sels. To analyze the cellular basis of this we have developed a 
model of restrictive pulmonary hypertension in the rat breath- 
ing high oxygen at normobaric pressure. Vascular changes 
begin within hours of injury and progress until virtually all 
microvessels are affected. Currently, little is known of the 
mediators that act as signal molecules but it is likely that 
ones released by inflammatory and vascular cells stimulate 
chemotaxis, proliferation and expression of contractile or- 
ganelles, as well as secretion of the matrix proteins. Light 
microscopy studies and quantitative methods of analysis pro- 
vide a broad understanding of the nature and extent of wall 
reorganization within the microvessel network. High resolu- 
tion studies, including the use ofimmunogold techniques, are 
critical to identify cell phenotype during the early stage of 
wall changes, and, later, the type of filament proteins expressed 
as cells switch phenotype by acquiring contractile organelles. 
• Only a few millimeters in length, but numerous, the 
microvessels are a critical site of restriction to blood flow in 
pulmonary hypertension. Myriads of these vessels regulate flow 
to and from the capillary network in the lung's alveolar re- 
gion, where most gas exchange occurs. In the adult human 
lung about 300 000 000 alveoli are each supplied by 1000 
capillary segments. 
In the normal lung, these vessel segments adjacent to capil- 
laries (pre- and postcapillary segments) are appropriate in size 
and structure for anatomic level, but injury changes this, thick- 
ening their wall by increasing cell mass and number. The re- 
sult of cell proliferation, in excess of the need for cell replace- 
ment, is lumen narrowing. When widespread, such changes 
effectively block the microvessels and are the structural basis 
of a maintained rise in pulmonary vascular resistance (PVR) 
and pulmonary arterial pressure (PAP). Constriction and hy- 
perreactivity, each responsible for a transient rise in PAP, of- 
ten are superimposed on a structurally restricted bed. In addi- 
tion to proliferating, the newly developing microvascular cells 
express contractile organelles, leading to the development of 
smooth muscle in previously nonmuscular segments of the 
circulation (neomuscularization). This review represents an 
overview of our experimental studies directed to understand- 





The focus of this review is microvascular wall remodeling in the 
adult lung. Similar changes restrict the microvascular bed in (i) 
primary pulmonary hypertension, including its idiopathic 
forms (arterial and venous) as well as chronic thromboem- 
bolism and perivenous obliteration, and (»') secondary pulmo- 
nary hypertension due to heart-lung disease, through a passive 
rise in pulmonary venous pressure, a reactive response to high 
flow, or vaso-occlusive disease (1). Vascular restriction also 
may occur in utero, or after birth, where changes are superim- 
posed on and alter the template of normal vessel growth (2). 
The several other vascular lesions that are associated with lu- 
men occlusion by wall cells, organizing thrombi, or intimal 
fibrosis, as in plexiform and angiomatoid lesions, necrotizing 
arteritis, and perivenous fibrosis, are discussed elsewhere (3 -5). 
It is important to note that although it is narrowing of the 
microvessels that so restricts the vascular bed, large arteries 
also narrow in the hypertensive lung (6-11). In these vessels 
the normally thick muscular wall is thickened further by pro- 
liferation of endothelial cells, smooth muscle cells (SMC) and 
fibroblasts, and by the increased deposition of collagen fibrils, 
as well as by other extracellular matrix components. Similar 
changes occur along the loops of increasingly smaller vessels 
that drain to and from the microvascular segments. Whether 
in these larger vessels the changes reflect a greater hemody- 
namic load that is independent of microvascular injury, or occur 
secondarily to microvascular injury and increase in pressure, 
is not fully understood. Wall remodeling in these vessels, as 
in the microvessels, is likely effected by processes that resemble 
ones in systemic vessels. That is (i) the sensing of signals that 
reflect hemodynamic conditions, (ii) the transduction of sig- 
nals within and between cells, and (iii) the synthesis and re- 
lease of mediators for cell growth, death, migration and ma- 
trix deposition (12). In lung vessels of all sizes, however, cell 
labeling studies demonstrate an effect before PVR and PAP 
increase, indicating an early response to mediators for vascu- 
lar cell growth. 
In considering how microvessels are restricted, it is evident 
that in addition to the proliferative changes described here, 
the lumen may be obliterated, blocked, or narrowed by a throm- 
bus or by cell swelling (1,7). In addition, the lumen may be 
narrowed by wall contracture or compression, as in interstitial 
fibrosis. Contracture, mediated by an endothelium-dependent 
remodeling process, results from a chronic decrease in blood 
flow (13). In the microvessels especially, the extent of the in- 
jury and differences in the susceptibility of cells determines 
whether a segment is obliterated or remains patent. If injury is 
severe, and necrosis and cell loss lead to wall obliteration, the 
structural changes are probably irreversible. If cell swelling 
or hypertrophy and hyperplasia lead only to lumen occlusion, 
lumen patency may be restored. High blood flow through a 
restricted bed, however, will further injure the artery wall and 
increase PVR, and so potentiate structural changes (14). The 
extent to which the residual vascular bed is stiff or hyperreac- 
tive (2) reflects wall changes that result from an imbalance in 
the synthesis and degradation of matrix proteins, and from 
the expression of endothelial cell-derived mediators for SMC, 
as well as from SMC function (12,15). 
NORMAL VESSEL STRUCTURE AND 
TECHNIQUES TO ASSESS WALL REMODELING 
• In the normal lung, along any vessel pathway from the 
hilum to periphery, as vessels branch into segments and be- 
come increasingly smaller in diameter, wall structure changes 
(16-18). Thus, the arrangement of cells and matrix compo- 
nents is different in proximal and distal segments of a single 
vessel pathway, and not necessarily the same at the equiva- 
lent branch-point of different pathways. This structural diver- 
sity must be considered when assessing wall changes in pul- 
monary hypertension. For ease, the wall structure of the 
microvessels is described here in relation to that of vessels 
throughout normal lung. 
•        Normal vessel structure  
In human adult lung, conventional pulmonary artery branches 
run with airways and share a single connective tissue sheath. 
Additional artery branches arise independently, and supply 
adjacent alveoli (16,17). These are termed "supernumerary" 
branches. At all levels, they are more numerous than conven- 
tional branches, and their number is greatest distally. Despite 
being more frequent they are narrower, however, and so their 
total cross-sectional area is less than that of conventional ar- 
teries. The pulmonary venous bed also has conventional and 
supernumerary branches (19). While the number of conven- 
tional veins and arteries is similar, the number of supernu- 
merary veins is greater. 
Near the hilum, where in cross-section the arterial wall has 
SMC and at least four additional elastic laminae inbetween 
the internal and external laminae, the vessels are termed elas- 
tic (16). Further distally, where the central laminae decrease 
to leave SMC between only an internal and an external lami- 
nae, the vessels are termed muscular (M). In these segments, 
the thickness of the medial muscle layer decreases as the ves- 
sel diameter decreases to about 500 Lim ED (external diam- 
eter), the thickness of the media here representing about 5% 
of the ED. At the entrance to the acinus, in vessels 250-500 
p.m ED, the medial thickness increases, representing up to 
20% of the ED. These segments represent the so-called "resis- 
tance segments", where wall thickness is relatively high for 
vessel diameter. Within the acinus, where the complete layer 
of medial SMC becomes incomplete, and spirals to form only 
a crescent in the wall (Fig.l), the vessels are termed partially   
48 Jones 
Biomed Rev 4,1995 
Vascular remodeling in pulmonary hypertension 
  
muscular (PM). These segments have a medial SMC layer be- 
tween an internal and external elastic lamina on one side of 
their wall, and only a single lamina and no SMC on the other. 
Distally, where the medial muscle layer disappears completely 
from the wall (Fig.l), the vessels are termed non-muscular 
(NM). Some of these segments have only an elastic lamina 
adjacent to endothelium (16). Others that are amongst the 
smallest of these segments (> 20 < 25 (im in diameter) have 
no elastic lamina (20). Because a similar arrangement of wall 
muscle is seen on the venous side it is difficult to identify 
small arteries from veins by wall structure alone. The larger 
veins (> 100 p,m) are readily identified from arteries by their 
position and thinner wall. 
In other mammalian species, including the rat (the species 
used in the experimental studies discussed here) supernumer- 
ary vessels are present and the distribution of intraacinar ves- 
sels is similar to that described for human lung in that M, PM 
and NM segments are present (1,6,8). 
From the hilum to lung periphery five cell types form the ves- 
sel wall in normal lung: the endothelial cell, the SMC and its 
two precursor cells, the intermediate cell and pericyte, and the 
adventitial fibroblast. Only the endothelial cell is found 
throughout the vascular bed, and precursor SMC are found 
only in the microvessels. In relation to matrix components, 
especially elastic laminae, the arrangement of cells within the 
vessel wall is characteristic. In the microvessels, the presence 
of cell types varies with the segment: endothelial cells lie in- 
ternally to a single or internal lamina and form the vessel in- 
tima. And, in segments where they are present, precursor cells 
lie beneath the endothelium within the intima, SMC lie be- 
tween an internal and external lamina and form the media, and 
fibroblasts lie abluminally to a single or external lamina and 
form the adventitia. The wall of some segments that have no 
lamina consists only of endothelial cells and basement mem- 
brane. These have a similar wall structure to capillaries but are 
larger in diameter. 
Reconstruction studies have shown that the single axial artery 
that enters the acinus divides into two tapering segments that 
branch with several generations of alveolar ducts before dis- 
persing into a capillary network in the alveolar wall (21). 
Normally, along the axial pathway, and in the NM segment 
adjacent to the endothelium, the processes of precursor cells 
form a thin attenuated layer (21-23). When most proximal, 
i.e. at the level of the second generation of alveolar ducts, 
these cells express a SMC phenotype (21). Further distally lie 
intermediate cells, so-called because they are intermediate in 
structure and location between SMC and pericytes. Like SMC 
they are enveloped in their own basement membrane but like 
pericytes they possess few filaments or dense bodies (21,23). 
In response to injury, intermediate cells become SMC by de- 
veloping additional contractile organelles (9,20,22). It has been 
suggested that in the smallest NM segments, pericytes, which 
are increasingly considered a contractile cell (24,25), simi- 
larly form a precursor cell population (9,20,22). 
  
 
Figure L Illustration of pulmonary artery wall showing arrangement of muscle. Along any one pathway from the hilum to 
lung periphery the structure of the wall changes as the muscle coat diminishes to form a spiral and then disappears from 
the wall. In cross-section the muscle layer may be complete (a muscular artery), incomplete (apartially muscular artery) or 











• Quantitative analysis of pulmonary vessels, with 
emphasis on the microvessels 
The normal vessel wall is constantly remodeled by homeo- 
static mechanisms. Wall remodeling in response to injury is 
an adaptive process in which mediators released by injured 
vascular cells, and by inflammatory cells, change prolifera- 
tion rates and matrix production. Hemodynamic forces also 
determine lumen size. In response to long-term changes in 
flow the endothelium, sensing change in shear stress, releases 
mediators that remodel the vessel wall, increasing lumen size 
to maintain an appropriate level of shear stress (12). 
Morphometric techniques applied to vessel populations in the 
normal and hypertensive lung establish the nature of wall 
changes, their extent, and precise location. For the purpose of 
this analysis, all patent vessels and the airways must be fully 
distended. For light microscopy studies, a radio-opaque sub- 
stance such as barium sulfate gelatin injected at a high dis- 
tending pressure (100 cm H,O) will fill patent vessels. Either 
the pulmonary arteries or veins can be injected since the in- 
jection medium does not cross the capillaries. The airways are 
then distended with fixative (23 cm H,O) to allow each vessel 
to be identified by its position in relation to airway structures. 
An alternative method that is particularly useful for ultrastruc- 
tural studies (23) is to distend both the vessels and airways 
with fixative, also at 100 cm H,O and 23 cm H,O, respec- 
tively. The presence of erythrocytes washed from the arterial 
to the venous side of the circulation assists in identifying small 
arteries from small veins. If the vascular bed cannot be dis- 
tended, then the area of medial muscle in the wall can be as- 
sessed to provide an index of change, but only after airway 
distention and "landmarking" can a vessel segment be pre- 
cisely located within the network. 
In our studies, we characterize vessels by wall structure (M, 
PM or NM) and size (ED), and use their accompanying air- 
way as a landmark (Fig.2). Within the acinus, vessels are as- 
sociated with respiratory bronchioli, or alveolar ducts, or lie 
within alveolar walls. The latter, including alveolar duct, com- 
prises the microvessels. When fully distended, it is relatively 
straightforward to measure the ED of these vessels and, for M 
and PM ones, the medial thickness (MT), i.e. the thickness of 
the muscle layer between the internal and external elastic 
lamina, to obtain an index of lumen narrowing. This value is 
related to vessel size by calculating the percent MT (% MT = 
2 x MT x 100/ED for M vessel segments or 1 x MT x 100/ED 
for PM vessel segments). As the MT increases and vessel di- 
ameter is reduced, the percent MT increases. A further index 
of microvascular restriction is obtained by the ratio of filled 
arteries to alveoli, providing an assessment of patent vessels 
that is independent of the degree of airway distention. 
 
Figure 2. Illustration of arrangement of pulmonary 
artery wall structure in relation to accompanying air- 
way level (bronchiole [B], terminal bronchiole [TBJ, 
respiratory bronchiole [RB], alveolar duct [AD] and 
alveolar wall [A W]). Typically, the resistance vessels, 
where vessel wall is thick for vessel diameter (see text) 
are found at the level of the TB. Near the entrance to 
the acinus the vessel wall changes from muscular to 
partially muscular. This may occur at the level of the 
RB (as shown) or more distally, at the level of the AD. 
Further distally along the pathway the wall changes to 
non-muscular. This may occur at the level of the AW 
(as shown) or more proximally, at the level of the AD. 
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The distribution of organelles within cells, and the arrange- 
ment of cells within the vessel wall, identifies cell phenotype - 
distinguishing endothelial cells from adjacent precursor cells, 
precursor cells from medial SMC, and adventitial fibroblasts 
from contiguous interstitial cells (20). While similar cell types 
are found in vessel walls in the normal and hypertensive lung, 
additional cell types are recognized in the latter in relation to 
wall remodeling (1,20). 
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EXPERIMENTAL STUDIES OF MICROVESSEL 
WALL REMODELING IN PULMONARY 
HYPERTENSION 
• In vivo models offer a unique opportunity to investi- 
gate the cellular basis of microvessel wall remodeling in a 
system in which crucial cell-matrix interactions are maintained 
(26). While breathing either a high or low oxygen, tension 
leads to widespread microvessel restriction and to the devel- 
opment of pulmonary hypertension. The pattern of restriction 
as shown by fractal analysis is not the same for the two inju- 
ries, restriction of the smallest vessels being greater in the 
hyperoxic lung where an inflammatory component is found 
(8,27). The effect of hypoxia on vessel wall remodeling, a 
metabolic injury with little evidence of an inflammatory re- 
sponse, has been well studied (9,26). Our interest in the effect 
of hyperoxia started with our studies of vascular changes in 
the lungs of patients dying of the adult respiratory distress 
syndrome. Over the course of days to weeks, these patients, 
who receive high oxygen tensions, develop pulmonary hyper- 
tension with a vascular bed that typically at first responds to a 
dilator but later becomes unresponsive (28). Vessels through- 
out the lung are affected (7,29). Because of the reported ef- 
fects of high oxygen tension on the lung, especially its damag- 
ing effect on capillaries, we studied the microvessels under 
such conditions to establish if injury would lead to pulmonary 
hypertension. During the first days of breathing high oxygen 
alveolar-capillary membrane cells show marked injury, and 
pulmonary edema is common. Adaptation occurs between Day 
3 and 4, and the edema largely resolves. This allows the de- 
velopment of a model of chronic vessel injury. 
•         The cellular basis of microvessel restriction 
By Day 7 of hyperoxia, wall thickening and right ventricular 
hypertrophy (RVH) are established and PAP increased (control, 
•17-18 mm Hg; hyperoxia, -26 mm Hg) and the vascular bed 
is more reactive to challenge (6,30). Interestingly, although the 
vascular bed as a whole is hyperreactive, reflecting mostly the 
response of the microvessels, the walls of vessels at the entrance 
to the acinus are stiff, at least in part because of extensive col- 
lagen deposition (30,31). Vascular injury, including a fall in 
the ratio of filled arteries to alveoli (a reduction of about one 
third by Day 7), progresses with time. By 4 weeks, in addition 
to wall thickening, the wall changes include lumen occlusion 
and obliteration (8). Both RVH and PAP are further increased 
(hyperoxia, 45-70 mm Hg) (7,8). In the hyperoxia-adapted 
lung, despite careful weaning (-10% less oxygen daily) over the 
course of one week, the challenge of relative hypoxia caused 
by return to breathing air leads to further injury (8). An increase 
in RVH early during the weaning period indicates a correspond- 
ing rise in PVR, and although RVH later falls, as does PAP 
(hyperoxia, 32 mm Hg), neither regain the normal value in the 
8-week "recovery" period that we studied in these animals (7). 
The extent of restriction in the hyperoxic lung after 4 weeks 
is well illustrated by arteriography (Fig.3a,b). There is a loss 
of small arteries filled with barium, and narrowed central and 
axial arteries. Venograms show that the small veins (about 
150 Jim ED) are similarly affected (32). Histologically, this 
pruning is seen to include both obliterative and occlusive le- 
sions (8). Many vessel remnants indicate continuing cell in- 
jury and the failure of these segments to adapt to hyperoxic 
conditions. Lumen narrowing is widespread (Fig.4a,b) and 
there is intimal accumulation of monocytes and hyalinization 
of the media (8). 
In the normal rat lung, about half the number of vessel seg- 
ments at the level of alveolar ducts, and most in alveolar walls 
have no medial SMC (Fig. 5). This provides clearly defined 
segments in which to follow muscle development in response 
to injury. Quantitative studies (8) demonstrate a significant 
increase in the percent MT of arteries, and a shift to vessels 
with medial muscle at the expense of NM ones (Fig.5). After 
2 weeks in air, thinning of the percent MT indicates regres- 
sion although paradoxically there is a further increase in the 
number of alveolar wall and duct segments with muscle (Fig. 
6,7). After 8 weeks in air, the number of vessels with muscle 
is below that after 2 weeks, and is less than at the end of 
hyperoxia, but is still greater than in normal lung (Fig. 6). In 
some animals, increased filling on the arteriogram suggests 
that lumen patency is restored to some vessels, indicating those 
in which the lumen was occluded by cell swelling (8). 
•         Cell proliferation 
By a standard pulse labeling technique in which [
3
H] thymi- 
dine is incorporated into vascular cells entering the synthetic 
phase of mitosis, we analyzed a series of time points to assess 
their proliferation during the course of wall remodeling, i.e. 
on days 1,4,7,10 and 28, counting the number of labeled cells 
per 1000 cells of the same type (33). This technique does not 
indicate the full extent of proliferation but rather the time when 
it peaks. The extent and timing of these bursts of activity is 
different for the same cell type at different levels within the 
lung, e.g. for endothelial cells in the microvessels or at the 
hilum, and for cell populations at the same level, e.g. for en- 
dothelial cells, SMC, precursor cells or fibroblasts in the 
microvessels. 
In normal lung, few microvascular cells label (33). Of these, 
most are fibroblasts and SMC, a few are endothelial cells and 
none are precursor cells. At the start of hyperoxia (Day 1) no 
microvascular cells are labeled, but by Day 4 the index is high 
for all cell types except the medial SMC. It is the labeling 
index of the fibroblast, however, that is strikingly increased 
(-20 fold)., While a high level of labeling then persists in 
these cells it does not again achieve this peak value. Most of 
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Figure 3. Rat pulmonary arteriograms (original magnification, x 2.5) illustrating restriction of the vascular bed in the 
hypertensive lung. (From Ref8, with permission), (a) Normal lung: filled vessels (>160[im ED) are discerned as separate lines 
and ones (<J60  pm ED) as a background haze. The background haze is dense and uniform, (b) Hyperoxic lung (87% 0, for 
28 days): loss of the background haze denotes non-filled small vessels. Narrowed axial and lateral branches are also evident. 
  
 
Figure 4. Rat alveolar wall arteries (4 \im sections stained with MEVG). In both vessels the lumen is distended with 
barium-gelatin sulfate.(From Ref 8, with permission), (a) Normal lung: thin-walled vessel with a single elastic lamina (72 
H/n ED, x 640). Alveolar wall vessels typically have this wall structure in normal lung, (b) Hyperoxic lung (87% O2 for 28 
days): a muscular artery with a well-developed media between an internal and external elastic lamina (53 jJ.ni ED, x 640). 
In pulmonary hypertension, alveolar wall vessels typically develop muscle cells that first lie internally to a single elastic 
lamina, and then are separated from the endothelium by the development of a second elastic lamina. The first lamina forms 
the external lamina within the vessel wall. The lamina that separates the newly developed contractile cells from the endo- 






















Figure 5. Percent of non-muscular (NM), partially 
muscular (PM) and muscular (M) vessels (<100 fjm 
ED) associated with alveolar ducts and in the alveolar 
wall. In hyperoxic pulmonary hypertension as vessel 
walls remodel the normal distribution of alveolar duct 
and wall vessels (Day 0) shifts (Day 28), as vessels 
with a medial muscle layer (M and PM vessels) in- 
crease at the expense ofNM ones (ptf 0.001 for both 
airway levels). 
the labeled flbroblasts are identified around vessels with no 
elastic lamina. 
The labeling index of the endothelial cell increases on Day 7 
(~10-fold) and then remains high. Labeled precursor cells are 
present on Day 4 when the highest labeling index occurs (—40- 
fold increase). While the relative number of proliferating cells 
is higher for the precursor cells than for flbroblasts the abso- 
lute number of proliferating flbroblasts is the greater (8). In the 
lum epon sections used for these studies it was not possible to 
identify cell phenotype. Despite a steady increase over time in 
the number of cells in the same location as the precursor cells, 
labeled precursor cells are not identified in large numbers af- 
ter this time, raising the question of their origin. Labeled mi- 
crovascular SMC are not identified until Day 28 and the 
extent of labeling is minimal compared to that for other cell 
types. After weaning and return to breathing air, the labeling 
index for each cell type is above normal but less so than dur- 
ing the first days of hyperoxia (33). 
Clearly, in the microvessels of the injured lung, SMC present 
between an internal and external elastic lamina are relatively 
slow to divide, as are the existing precursor cells lying inter- 
nally to an elastic lamina. A remarkable feature is the high 
labeling of fibroblasts as these cells are recruited to and align 
Figure 6. Percent of non-muscular (NM), partially 
muscular (PM) and muscular (M) vessels associated 
with alveolar ducts and in the alveolar wall. After wean- 
ing and return to breathing air, the number of vessels 
with muscle increases at the expense ofNM ones (ptf 
0.001 for both airway levels when compared to the dis- 
tribution of vessels in normal lung). After 2 weeks in 
air, in response to the relative hypoxia of air, the num- 
ber of alveolar duct and wall PM and M vessels is 
higher than at Day 28 (increasing from 40 to 54 % and 
from 34 % to 45 %; and from 40 to 62 % and from 23% 
to 32 % for these vessel populations respectively, com- 
paring values after 2 weeks in air with those shown for 
Day 28 in Fig.5). After 8 weeks in air vessels with 
muscle persist, although their number decreases sig- 
nificantly (p%
2
 0.001 for both airway levels when com- 
pared to the distribution of vessels after 2 weeks in 
air). In the most distal region of the lung, however, 
PM and M vessel numbers remain similar to those at 
the end of hyperoxia (being 40 and 59 % and 23 and 
20 %for alveolar wall vessel populations respectively, 
comparing values after 8 weeks in air with those shown 
for Day 28 in Fig 5). 
around vessel walls. It is particularly to microvessel segments 
in regions of the interstitium disrupted and expanded by edema 
that these cells migrate. As they are incorporated into the ves- 
sel wall by the formation of an elastic lamina along their 
abluminal edge (20,22) this effectively converts them into a 
precursor cell layer beneath the endothelium. Thus, it is the 
recruitment and proliferation of flbroblasts that contributes 
most to the increasing number of precursor cells appearing 
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To further understand the proliferative response described here, 
and ultimately to devise ways to prevent it, the growth factors 
expressed by lung cells are of great interest. The major fami- 
lies that have been investigated are epidermal growth factor 
(EOF), which includes heparin-bindingepidermal-like growth 
factor (HB-EGF), transforming growth factor- p (TGF-P,, TGF- 
P2 and TGF-P5), acidic and basic fibroblast growth factor (aFGF 
and bFGF), insulin-like growth factor (IGF I and II), platelet- 
derived growth factor (PDGF A and B) and tumor necrosis 
factor-a (TNF-a). Inflammatory cells (alveolar macrophages, 
monocytes and leukocytes) and mast cells are their likely source 
as are the vascular cells themselves (15). Working in concert, 
these cells synthesize and release regulatory molecules that 
act through autocrine, paracrine, or, in some cases, juxtacrine 
pathways (34). To date, studies of the hypertensive lung, al- 
though rather limited, indicate that ligands from each family 
play a role (6,35-42). Further studies are needed to identify 
temporal and spatial changes in gene expression for these 
ligands and their receptors. In addition, immunocytochemical 
studies to identify sites of biologically active protein are needed. 
How cells switch on and off their response in a tissue satu- 
rated with growth factors is an intriguing question, involving 
the effect of these factors on interactions between cellular and 
matrix components, via adhesion molecules (see 43,44). 
• Neomuscularization (transdifferentiation of non-con- 
tractile to contractile cells) 
Neomuscularization of the vessel wall includes the development 
of a new layer of intimal contractile cells and organization of 
these cells into a medial layer (1,20). Cells express filament 
proteins and assemble an intracellular filament system 
(Fig.7a,b) via a process of phenotypic switching, or transdiffe- 
rentiation, as they adapt to their environment in the vessel wall 
(20,45). The development of contractile organelles follows cell 
proliferation and organization within the wall. Reconstruction 
of vessel profiles shows that new contractile cells appear only 
in the wall of NM segments of the microcirculation, i.e. they do 
not develop internally to a medial layer (20). 
In the hyperoxic lung, intermediate cells quickly produce fila- 
ments and dense bodies (by Day 3). Often these filaments run 
parallelly to the longitudinal orientation of the cell and oc- 
cupy the adluminal edge. Filament production in fibroblasts 
is delayed until about Day 7. Only after their alignment around 
a vessel, possibly in response to a chemotactic factor such as 
endothelin-1 being released by injured endothelial cells (46), 
and their incorporation into the wall, do these cells express 
filaments in large numbers. How these cells relate to the con- 
tractile interstitial cell and myofibroblast typical of the 
interstitium in normal lung, or in response to injury, is not yet 
established (47-49). Nor is it yet known if the fibroblasts that 
form the vessel wall evolve into contractile cells that are 
pericytic, or if indeed they first become pericytes and then 
develop contractile organelles. In rat mesenteric vessels, fi- 
broblasts migrate to the basement membrane of newly devel- 
oping capillaries during angiogenesis and become enclosed in 
basement membrane leaflets of these cells, so becoming 
pericytes (50). While this may occur in the smallest vessel 
segments in the hypertensive lung, thereby increasing the num- 
ber of pericytes in these vessels, the pattern in segments where 
fibroblasts align is more complex since it involves the forma- 
tion of an elastic lamina before the expression of contractile 
organelles. 
New basement membranes form around vascular cells follow- 
ing their proliferation. In general this consists of a fine network 
of collagenous and non-collagenous glycoproteins that sepa- 
rates the cell from the surrounding matrix, acts as a selective 
barrier, and stimulates cell differentiation, morphogenesis and 
movement (51). The main components, type IV collagen and 
laminin, self-assemble into a structural network to which other 
components, such as heparan sulfate proteoglycan (perlecan), 
chondroitin sulfate proteoglycan, entactin (nido-gen), tenascin 
and fibronectin, bind (51,52). Each of the component of the 
membrane is known to influence cell-matrix interactions. 
These include cell adhesion, spreading, polarization, move- 
ment, and proliferation, as well as phenotype. While the com- 
ponents of the membrane change in pulmonary hypertension 
(52) little is yet known of the molecular components of the 
basement membrane of individual vascular cell types. Its struc- 
tural organization and its function as a source of cell signaling 
molecules has been discussed by Yurchenco and O'Rear (53) 
and by Vlodavsky and colleagues (54). While it may be ex- 
pected that growth factors stored in the basement membrane 
will exert a local effect on cells, it is increasingly clear that this 
interaction is regulated by matrix components (55). 
The development of a first or second elastic lamina, along the 
abluminal and adluminal edge of cells respectively, defines a 
new intimal or medial layer in the vessel wall. At this site, as 
for basement membrane, little is known of the assembly of the 
laminae. In other tissues, elastic fiber microfibrils aggregate 
in parallel arrays often occupying Moldings of the cell mem- 
brane (56,57). These act as a scaffold where elastin is depos- 
ited as small clumps of amorphous material within the aggre- 
gates which then coalesce to form elastic fibers. Tropoelastin, 
secreted by cells into the surrounding matrix, accretes onto 
the surface of the developing elastic fiber where it interacts 
with the microfibrils and is aligned for cross-linking. Recently, 
three molecules have been identified as microfibril compo- 
nents: (/') 31 kD microfibril-associated glycoprotein, (») 350 
kD glycoprotein, fibrillin (58,59), and (Hi) 35 kD protein with 
amine oxidase activity. Further studies are needed to analyze 
these components of the laminae and their assembly during 
wall remodeling in the lung microvessels.   
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Figure 7. Transmission electron micrographs of alveolar wall vessels, (a) Normal lung: non-muscular vessel (25 jMn ED, 
x 3954); endothelial cell (e), interstitial fibroblast (if), epithelial type 2 cell (ep). At higher magnification, an additional 
cell (at open arrow) was classified as an intermediate cell (not shown). (From Ref20, with permission), (b) Hyperoxic lung 
- vessel (J5.5fJ.rn ED, x 8750):with contractile cells forming a sub endothelial cell layer (28 days at 87% O2 ). Subendothelial 
cell process (*) lie adluminally to a well-defined electron-dense elastic lamina (el) and abluminal to endothelial cells (e). 
Basal lamina is evident along the abluminal cell edge (small arrows), and focal elastin deposits adluminally (single arrow- 
heads). The newly developed cells are triangular with the features of a contractile cell; microfilaments are heavily distrib- 
uted throughout the cell process at the top, less in the process in the lower region of the wall, and, at high magnification, 
dense bodies are seen. Interstitial fibroblast (if), alveolus (alv). (From Ref. 20, with permission) 
  
The current lack of detailed knowledge of how the new cells 
organized their filament system in the normal or hypertensive 
lung reflects in part the need to apply special techniques to pre- 
serve antigcnic structures for high resolution studies. In sec- 
tions of lung vessels examined by transmission electron micros- 
copy only the filament network of actin are visible. Typically, 
actin filaments are expressed in the leading edge of migrating 
cells and in the subnuclear region of cells aligning in the ves- 
sel wall. The use of special fixation and low temperature pro- 
cessing techniques to preserve intermediate filament and myo- 
filament structures will allow us to establish the relevant pro- 
teins, including the expression of actin isoforms, intermediate 
filament proteins, and different forms of myosin. Actin is usu- 
ally abundant in the filaments of all cells, and present with myo- 
sin in the myofilaments of SMC, where the y-smooth muscle 
actin isoform predominates. As in systemic vessels, it is likely 
that different lung vascular cells express different intermedi- 
ate filaments composed of either vimentin or desmin (60,61). 
In several species, there is evidence of heterogeneity of myo- 
sin expression in vascular cells (62), as for example in the 
medial cells of large and small muscular arteries which express 
smooth muscle myosin, and in those of large elastic arteries 
which express nonmuscle myosin. At sites other than lung, 
there is evidence that the filaments of vascular contractile cells 
change in response to injury (63) and, in lung, evidence of such 
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similar changes occur in the vessels of the lung is not known. 
Nor is it known whether in injured microvessels, as in large 
arteries, it is the cytoskeletal or contractile filaments that in- 
crease (66), in addition to increase in matrix protein secretion. 
From several studies there is emerging evidence that lung cells 
modulate their expression of contractile proteins in response 
to growth mediators. How this is linked to functional demands 
remains to be determined. Following their development in the 
wall of distal lung vessels, contractile cells can migrate through 
disruptions in the endothelium to occlude the lumen, by cell 
proliferation and collagen synthesis. 
CONCLUSIONS 
• The walls of the pre- and postcapillary microvessel seg- 
ments thicken and develop contractile cells in response to the 
injuries leading to the development of pulmonary hyperten- 
sion. This site of restriction to blood flow is the structural 
basis of maintained rise in pressure. Wall remodeling is pro- 
gressive and is the result of cell hypertrophy and hyperplasia 
in response to growth mediators synthesized in excess of the 
need for cell replacement. New contractile cells develop from 
precursor cells - intermediate cells and possibly pericytes - 
within the vessel wall, and interstitial fibroblasts recruited to 
it. The organization of these cells into layers within the wall 
is effected by formation of basement membranes and elastic 
laminae. This stage is associated with the expression of pro- 
teins responsible either for organization of the supporting cell 
matrix or for the filaments associated with cell contraction. 
This converts capillary-like segments adjacent to the capillary 
bed into thick-walled resistance vessels. 
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